Document:

ex4.htm

    
      

      

    

    January
14, 2010

     

    Ore-More
Resources Inc.

    1530,
9th
Avenue SE

    Calgary,
AB T2G 0T7

    

    Dear
Sir:

    

    Re:  Cougar
Energy, Inc and Kodiak Energy, Inc.

    

    This
Letter Agreement is to evidence the agreement between Zentrum Energie Trust AG
(“Zentrum”) and Ore-More Resources Inc. (“Ore-More”) concerning Kodiak Energy,
Inc. (“Kodiak”).  The terms of the agreement are as set forth under
the headings below.

     

    
      	
               
      

            	
              The
      Indebtedness

            

    

     

    Zentrum
has represented to Ore-More that Kodiak is indebted to Zentrum in an amount of
$1,357,713.70 as at December 31, 2009 (the “Indebtedness”).

     

    
      	
               
      

            	
              The
      Security

            

    

     

    Zentrum
has also represented to Ore-More that it holds security in relation to the
Indebtedness which includes the following:

     

    
      	
               
      

            	
              Promissory
      Note executed by Kodiak dated September 30,
  2009;

            

    

     

    
      	
               
      

            	
              General
      Security Agreement executed by Kodiak dated September 30,
      2009;

            

    

     

    
      	
               
      

            	
              Debenture
      executed by Kodiak dated September 30,
2009;

            

    

     

    
      	
               
      

            	
              Pledge
      executed by Kodiak dated September 30,
2009;

            

    

     

    
      	
               
      

            	
              Negative
      Pledge and Undertaking executed by Kodiak dated September 30,
      2009;

            

    

     

    
      	
               
      

            	
              Share
      Pledge executed by Kodiak dated September 30,
  2009;

            

    

     

    
      	
               
      

            	
              Guarantee
      executed by Cougar Energy, Inc. (“Cougar”) dated September 30,
      2009;

            

    

     

    
      	
               
      

            	
              General
      Security Agreement executed by Cougar dated September 30,
      2009;

            

    

     

    
      
         

      

      
        1

        
          

        

      

      
         

        
           

        

      

    

    
      	
               
      

            	
              Debenture
      executed by Cougar dated September 30,
2009;

            

    

     

    
      	
               
      

            	
              Pledge
      executed by Cougar dated September 30,
2009;

            

    

     

    
      	
               
      

            	
              Negative
      Pledge and Undertaking executed by Cougar dated September 30, 2009;
      and

            

    

     

    
      	
               
      

            	
              All
      other security held by Ionic in relation to Kodiak and/or the
      Indebtedness.

            

    

     

    All such
security as described in (a) to (l) above shall hereinafter be called the
“Security”.

     

    
      	
               
      

            	
              Acquisition

            

    

     

    Ore-More
has agreed to purchase from Zentrum, and Zentrum has agreed to sell to Ore-More,
the Indebtedness and the Security (together called the “Sold Assets”) on the
Closing Date as described below.  The completion of such transaction
on that date shall hereinafter be called the “Closing”.  On the
Closing the Sold Assets shall be assigned to Ore-More by Zentrum free and clear
of all encumbrances, liens, mortgages, charges, hypothecations and adverse
claims created by Zentrum.

     

    
      	
               
      

            	
              Consideration

            

    

     

    In
consideration for the sale by Zentrum of the Sold Assets, Ore-More shall pay
Zentrum consideration the entire Indebtedness by issuing shares of Ore-More from
Treasury at the value of $6.00 per share USD. Total shares to be issued to
Zentrum with exchange rate of January 2/2010 of .9552
yields  $1,296,888/6 = 216,148 shares of Ore-More.

    

    
      	
               
      

            	
              Closing

            

    

     

    The
Closing of the transaction contemplated herein shall occur no later than the
first business day after execution and delivery of this Letter Agreement by both
parties (the “Closing Date”).  On the Closing Date Ore-More shall
provide the consideration to Zentrum as set forth above and Zentrum shall
execute and deliver to Ore-More all such assignment documents as which Ore-More
may reasonably request of Zentrum in order to fully assign, transfer, set over
and convey the Sold Assets to Ore-More on the basis described
herein.

     

    
      	
               
      

            	
              Zentrum’s
      Warranties and Representations

            

    

     

    Zentrum
hereby covenants, warrants and represents to Ore-More that:

     

    It has
the requisite corporate power and authority to enter into this Letter Agreement
and to perform its obligations hereunder and has taken all necessary corporate
action to authorize the sale of the sold assets in accordance with the terms
hereof;

     

    Zentrum
has title to the Sold Assets such that they may be sold to Ore-More hereunder
free and clear of all encumbrances, liens, mortgages, charges, hypothecations
and adverse claims created by Ionic; and

     

    
      
         

      

      
        2

        
          

        

      

      
         

        
           

        

      

    

    This
Letter Agreement has been duly executed and delivered by Zentrum and constitutes
legal, valid and binding commitments on the part of Ionic.

     

    Zentrum
makes no other warranties or representations except as expressly set forth above
in this document.

     

    Except as
set out in this Letter Agreement the Sold Assets are being assigned “as is where
is” without warranty or representation.

     

    
      	
               
      

            	
              Announcements

            

    

     

    Zentrum
and Ore-More shall not make any public announcements or statements referring to
this transaction, without the prior consent of the other party
hereto.

     

    
      	
               
      

            	
              Further
      Assurances

            

    

     

    At the
Closing and thereafter as may be necessary, and without further consideration,
the parties hereto shall execute, acknowledge and deliver such further and other
instruments and documents and shall take such other action and give such further
assurances as may be necessary to carry out their respective obligations
hereunder.

     

    
      	
               
      

            	
              Governing
      Law

            

    

     

    This
Agreement shall in all respects be subject to and shall be interpreted,
construed and enforced in accordance with the laws in effect in the Province of
Alberta.

     

    
      	
               
      

            	
              Time

            

    

     

    Time
shall be of the essence of this Letter Agreement.

     

    
      	
               
      

            	
              Entire
      Agreement

            

    

     

    This
Letter Agreement contains the entire agreement between the parties with respect
to the sale and purchase of the Sold Assets.  This Letter Agreement
supersedes and replaces any and all prior agreements and arrangements between
the parties and this agreement may be amended only be written instrument,
executed and delivered by each of the parties hereto.  This Letter
Agreement is enforceable and binding on the parties.

     

    
      	
               
      

            	
              Enurement

            

    

     

    This
Letter Agreement shall be binding upon and shall enure to the benefit of Zentrum
and Ore-More and their respective successors and assigns.

     

    
      	
               
      

            	
              Counterparts

            

    

     

    This
Agreement may be executed in any number or counterparts and delivered by
facsimile, each of which shall be deemed to be an original and all of which
taken together shall be deemed to constitute one and the same instrument, and it
shall not be necessary in making proof of this Agreement to produce or account
for more than one such counterpart.

     

    
      
         

      

      
        3

        
          

        

      

      
         

        
           

        

      

    

    If
Zentrum agrees to the terms and conditions set forth in this Letter Agreement,
we would ask that it sign in the place provided below on the enclosed copy of
this Letter Agreement, and return it to us.

     

    Yours
very truly,

     

    Ore-More
Resources Inc

     

    Per:
/s/ Lee Lischka         

    

    Zentrum
Energie Trust AG. hereby agrees to the terms and conditions set forth in this
Letter Agreement.

    

    ZENTRUM
ENERGIE TRUST AG

     

    Per: Guido
Hilekes                                                   

     

    
      
         

      

      
        4

        
          

        

      

      
         

        
        

      

    

    

    ASSIGNMENT
OF DEBT AND SECURITY

    

    THIS
ASSIGNMENT made the fourtheen day of January, 2010

    

    BETWEEN:

    

    ZENTRUEM ENERGIE TRUST AG, a body
corporate (hereinafter referred to as the “Assignor”)

    

    ORE-MORE RESOURCES INC, a body
corporate (hereinafter referred to as the “Assignee”)

    

    WHEREAS:

    

    
      	
              A.  

            	
              Kodiak
      Energy, Inc. (the “debtor”) is currently indebted to the Assignor in the
      amount of $1,357,713.70 CAD.  Which amount includes all
      principal, interest and other charges accrued to December 31, 2010. (the
      Indebtedness”)

            

    

    
      	
              B.  

            	
              As
      security for the Indebtedness and all other obligations owing by the
      DEBTOR to the Assignor, the Assignor has been granted and does now hold
      all of the security and guarantees set forth in Schedule “A” attached
      hereto (the Security”);

            

    

    
      	
              C.  

            	
              The
      Security has been perfected at certain public registries, the details of
      which are set forth in Schedule “b” attached hereto (the “Registrations”);
      and

            

    

    
      	
              D.  

            	
              Pursuant
      to a letter agreement between the Assignor and the Assignee dated January
      4, 2010 9 the “Letter Agreement”), the Assignor has agreed to assign and
      transfer to the Assignee all of its interest in and to the Indebtedness,
      the Security and the Registrations.

            

    

    

    NOW AND
THEREFORE in consideration of the 216,148  shares of Ore-More
Resources, Inc issued to Zentrum, and for good and other valuable consideration
paid by the Assignee to the Assignor, the receipt and sufficiency of which is
hereby acknowledged, the parties covenant and agree as follows:

    

    
      	
              1.  

            	
              The
      Assignor hereby assigns, transfers, sets over and conveys unto the
      Assignee all of the Assignor’s right, title, estate and interest in and to
      the Indebtedness, the Security and the Registrations, and all mortgages,
      charges, enclubmrances and security interests evidenced there by or
      contained therein, together with full power and authority to demand,
      collect sue for, enforce recover, receive and give receipts for the
      payments due thereunder, TO HVAE AND TO HOLD the same for its sole use and
      benefit absolutely subject nevertheless to the terms and conditions of
      this Assignment.

            

    

    
      	
              2.  

            	
              The
      Assignor appoints the Assignee as its agent for the limited purpose of
      transferring the Registrations into the name of the Assignee by making
      such filings as may be necessary therefore at the public registries set
      forth in Schedule “B”.

            

    

    
      	
              3.  

            	
              The
      Assignee here by covenants and undertakes to the Assignor to transfer all
      Registrations into the name of the Assignee by making such filings as may
      be necessary therefore at the public registries set forth in Schedule
      “B”.

            

    

    
      
         

      

      
        5

        
          

        

      

      
         

        
           

        

      

    

    
      	
              4.  

            	
              The
      provisions hereof shall enure to the benefit of all the heirs, executors,
      administrators, legal representatives, successors and assigns of the
      Assignor.

            

    

    
      	
              5.  

            	
              Subject
      only to the Letter Agreement, this Agreement constitutes the entire
      agreement between the parties relating to the subject matter
      hereof.

            

    

    
      	
              6.  

            	
              This
      Agreement may be executed in separate counterparts and when a counterpart
      has been executed by each party all counterparts, when taken together will
      constitute one agreement and will have the same force and effect as if all
      the persons executing such counterparts had executed the same
      agreement.

            

    

    
      	
              7.  

            	
              A
      faxed copy of an executed document or of an executed counterpart will be
      acceptable as if it were an originally executed
  document.

            

    

    

    IN
WITNESS WHEREOF the parties have executed this Agreement as of the date first
above written.

    

    ZENTRUM  ENERGIE TRUST
AG

    

    Per:  _________________________

    

    

    ORE-MORE RESOURCES INC

    

    Per:  _________________________

     

    
      
         

      

      
        6

        
          

        

      

      
         

        
           

        

      

    

    

    SCHEDULE
“A”

    

    

    Security:

    

    
      	
              1.  

            	
              A
      Promissory Note, executed by the Debtor dated September 30,
      2009.

            

    

    
      	
              2.  

            	
              A
      General Security Agreement executed by the Debtor dated September 30, 2009
      granting the Assignor a security interest in all of the Debtors present
      and after acquired personal property and all proceeds
    thereof;

            

    

    
      	
              3.  

            	
              A
      Debenture executed by the Debtor in favour of the Assignor dated September
      30, 2009, providing a security interest and mortgaging and charging all of
      the undertaking, property and assets of the Debtor for the time being,
      whether now owned of hereafter acquired both present and
      future;

            

    

    
      	
              4.  

            	
              A
      Debenture Pledge Agreement executed by the Debtor in favour of the
      Assignor dated September 30, 2009 pledging all obligations, debts and
      liabilities, present or future, direct or indirect, absolute or
      contingent, matured or not, at any time owing by the Debtor to the
      Assignor;

            

    

    
      	
              5.  

            	
              A
      Negative Pledge Agreement and Letter of undertaking executed by the Debtor
      in favour of the Assignor dated September 30,
  2009.

            

    

    
      	
              6.  

            	
              A
      Guarantee executed by Cougar Energy, Inc. in favour of the Assignor dated
      September 30, 2009 guaranteeing all indebtedness of the Debtor and all
      liability, present or future, absolute or contingent, from time to time
      and at all times pursuant to the Credit Agreement between eh Assignor and
      the Debtor;

            

    

    
      	
              7.  

            	
              A
      general Security Agreement executed by Cougar Energy, Inc. in favour of
      the Assignor dated September 30, 2009, granting the Assignor a security
      interest in all of Cougar Energy, Inc.’s present and after acquired
      personal property and all proceeds
thereof;

            

    

    
      	
              8.  

            	
              A
      Debenture executed by Cougar Energy, Inc. in favour of the Assignor dated
      September 30, 2009, providing a security interest and mortgaging and
      charging all of the undertaking, property and assets of Cougar Energy,
      Inc. for the time being, whether now owned of hereafter acquired both
      present and future;

            

    

    
      	
              9.  

            	
              A
      Debenture Pledge Agreement executed by Cougar Energy, Inc. in favour of
      the Assignor dated September 30, 20099, pledging all obligations, debts
      and liabilities, present or future, direct or indirect, absolute or
      contingent, matured or not, at any time owing by Cougar Energy, Inc to the
      Assignor;

            

    

    
      	
              10.  

            	
              A
      negative Pledge Agreement and Letter of Undertaking executed by Cougar
      Energy, Inc. in favour of the Assignor dated September 30, 2009;
      and

            

    

    
      	
              11.  

            	
              All
      other security held by the Assignor in relation to the Debtor and/or the
      Indebtedness.

            

    

    

    
      
         

      

      
        7

        
          

        

      

      
         

        
        

      

    

    SCHEDULE
“B”

    

            

    

       

      
        	  Registrations	 	 	 	 	 
	 	 	 	 	 	 
	 Registration
      number  	 	 Registration
      Type  	 	 Registration
      Date	 
	 	 	 	 	 	 
	 	 	 Security
      Agreement    	 	 2009-Dec
      15	 
	 	 	 	 	 	 
	 	 	 Land
      Charge 	 	 2009-Dec
      15	 
	 	 	 	 	 	 
	 	 	 Security
      Agreement  	 	 2009-Dec
      15	 
	 	 	 	 	 	 
	 	 	 Land
      Charge 	 	 2009-Dec	 
	 	 	 	 	 	 

      

       

    

                                                                                                                                                                     

    
      
         

      

      
        8ex-10_1.htm

    
      

      

    

    Adamis Pharmaceuticals Corporation
8-K

    

    

    Exhibit
10.1

    

    

    SECURITIES PURCHASE
AGREEMENT

    

    This
Securities Purchase Agreement (“Agreement”) is entered into as
of January 11, 2010 by and between ADAMIS PHARMACEUTICALS CORPORATION, a
corporation organized under the laws of the State of Delaware (the “Company”), on the one hand,
and each Person set forth on the signature page hereto as a “Purchaser”
hereunder (each a “Purchaser” and collectively
the “Purchasers”), on
the other hand.

    

    WHEREAS,
subject to the terms and conditions set forth in this Agreement, the Company
desires to issue and sell to each Purchaser, and each Purchaser, severally and
not jointly, desires to purchase from the Company, Notes of the Company in a
PIPE Transaction as set forth herein; and

    

    WHEREAS,
pursuant to that certain Agreement and Plan of Reorganization (“Merger Agreement”) dated as of
December 4, 2009 by and among La Jolla Pharmaceutical Company, a Delaware
corporation (“La
Jolla”), Jewel Merger Sub, Inc., a Delaware corporation and wholly-owned
subsidiary of La Jolla (“Merger
Sub”), and the Company, the Company has agreed to enter into a business
combination transaction with La Jolla pursuant to which Merger Sub will merge
with and into the Company (“Merger”) with (a) La Jolla
effecting a reverse stock split of its common stock, $0.01 par value per share
(“La Jolla Common
Stock”), immediately prior to the Merger, (b) the Company continuing
after the Merger as the surviving corporation and wholly-owned subsidiary of La
Jolla, and (c) each outstanding share of Company Common Stock being converted
into the number of shares of La Jolla Common Stock equal to the Exchange Ratio
(as defined in the Merger Agreement), each of (a) through (c) occurring in
accordance with the provisions of the Merger Agreement;

     

    NOW
THEREFORE, in consideration of the foregoing premises and the covenants
contained herein, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Company and each Purchaser
agree as follows:

    

    
      	
              1.

            	
              Incorporation by
      Reference; Definitions.

            

    

    

    
      	
              (a)

            	
              Incorporation.  This
      Agreement incorporates by reference, as if set forth herein in its
      entirety and including without limitation all terms, conditions and
      provisions set forth therein, the PipeFund Services Organization Standard
      Transaction Document labeled GTC 10-09 (General Terms and Conditions)
      available and accessible at www.pipefund.com
      (“PST Document
      GTC”); provided,
      however, that to the extent any of the terms, conditions or
      provisions of PST Document GTC contradict or conflict with the terms,
      conditions or provisions of this Agreement, this Agreement shall
      control.

            

    

    

    
      	
              (b)

            	
              Defined
      Terms.  Each initially capitalized term used but not
      defined in this Agreement (including PST Document GTC as incorporated
      herein pursuant to the preceding Section), and each initially capitalized
      term used but not defined in any other Transaction Document, shall have
      the meaning ascribed thereto in the PipeFund Services Organization
      Standard Transaction Document labeled 10-09 DEF (Definitions) available
      and accessible at www.pipefund.com.

            

    

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

    
      	
              (c)

            	
              Post
      Merger.  After the closing of the Merger, as used in the
      Transaction Documents (i) the term “Company” shall refer to the Company
      and La Jolla collectively, (ii) the term “Subsidiaries” shall refer to the
      Company’s and La Jolla’s Subsidiaries collectively, (iii) the term “Notes”
      shall include the Notes (as may be amended and/or restated) and any
      promissory notes, debentures, bonds or other debt instruments issued by La
      Jolla to the holders of Notes in substitution for the Notes being issued
      hereunder, (iv) the term “Common Stock” shall refer to La Jolla Common
      Stock, and (v) the term “Collateral” shall include all assets of La Jolla
      and its subsidiaries in addition to all the assets of the Company
      immediately preceding the Merger.  Any other terms which by
      their context are intended to relate to La Jolla in lieu of the Company
      following the Merger shall be so construed as
  appropriate.

            

    

    

    
      	
              (d)

            	
              PipeFund Transaction
      Code.  This Securities Purchase Agreement shall be known
      as “Securities Purchase Agreement
#ADMP-09-A”.

            

    

    

    2.    Securities.  The
Company agrees to issue and sell, and each Purchaser agrees to purchase,
severally and not jointly, in consideration for payment by such Purchaser of its
Subscription Amount indicated on such Purchaser’s signature page hereto, upon
the terms and conditions contained in this Securities Purchase Agreement, the
following Securities:

    

    
      	
              (a)

            	
              Notes.  10%
      Senior Secured Convertible Notes of the Company, in the form attached
      hereto as Exhibit A
      (“Notes”), with an
      aggregate original principal amount equal to such Purchaser’s Subscription
      Amount, which Notes shall (i) bear interest at 10% per annum, (ii) be
      convertible into shares of Common Stock at a Conversion Price of $0.20 per
      share, (iii) be secured by a first priority perfected security interest on
      all the assets of the Company and its Subsidiaries (including the
      “Collateral” as defined in the Security Agreement) (except to the extent
      set certain security interests are not perfected as set forth in the
      Security Agreement), and (iv) mature on the date which is nine (9) months
      following the Closing Date; and

            

    

    

    
      	
              (b)

            	
              Common
      Stock.  A number of Shares of the Company’s Common Stock
      equal to such Purchaser’s Subscription Amount divided by $1.00.
      

            

    

    

    3.    Specific
Terms.

    

    
      	
              (a)

            	
              The
      Minimum Aggregate Investment Amount shall be $1,000,000, and the Maximum
      Aggregate Investment Amount shall be
$1,500,000.

            

    

    

    
      	
              (b)

            	
              The
      Bulletin Board shall constitute an additional Eligible
    Market.

            

    

    

    
      	
              (c)

            	
              “Exempt
      Issuance” shall also include any issuance of securities pursuant to
      acquisitions, in-licensing of the Company’s Intellectual Property,
      products or services, or other strategic transactions, in each case
      approved by a majority of the members of the Board of Directors, provided
      in each case any such issuance shall only be to a Person (or to the
      shareholders or other equity owners of such Person) which is, itself or
      through its subsidiaries, an operating company engaged in significant
      business activities synergistic with the business of the Company and in
      which the Company receives benefits in addition to the investment of funds
      (if any), but shall not include (i) a transaction in which the Company is
      issuing securities primarily for the purpose of raising capital or to an
      entity whose primary business is investing in securities or (ii) any
      issuances in connection with the Merger or acquisition, purchase or
      licensing of assets (including any equity interests) from La Jolla or its
      affiliates.

            

    

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    

    
      	
              (d)

            	
              Requisite
      Purchasers means 67%-in-Interest of the Purchasers (with such
      67%-in-Interest determined solely based on the outstanding principal
      amount of Notes held by the Purchasers so long as any Notes are
      outstanding, and thereafter based on the number of Shares purchased
      hereunder and held by the
Purchasers).

            

    

    

    
      	
              (e)

            	
              The
      Placement Agent is Shoreline
Pacific.

            

    

    

    4.    Closing
Procedure.

    

    
      	
              (a)

            	
              Documents
      Delivery.  There shall not be any Escrow Agreement or
      Documents Escrow Agreement.  On or prior to the Closing Date,
      the Company shall deliver original executed copies of each Note to Company
      counsel with a copy to Peter J. Weisman, P.C.  Issuer’s counsel
      shall (a) hold each such Note in trust on behalf of the Purchasers and the
      Company, and (b) deliver each such Note to the applicable Purchaser named
      therein promptly following the Company’s acknowledgment that it has
      received the Subscription Amount from the Purchaser of such
      Note.  All other Company Closing Documents shall be delivered to
      Peter J. Weisman, P.C. on or prior to the Closing Date to hold in trust on
      behalf of the Purchasers and the Company.  A stock certificate
      or other reasonably acceptable evidence of ownership of the Shares being
      issued to each Purchaser hereunder shall be delivered to each such
      Purchaser, in the name of such Purchaser, within five (5) Trading Days
      following the Closing Date.

            

    

    

    
      	
              (b)

            	
              Condition
      Subsequent.  As a condition subsequent to the Closing,
      within five (5) Trading Days following the Closing Date, the Company shall
      cause to be delivered to the Purchasers evidence (reasonably satisfactory
      to the Requisite Purchasers) that the outstanding amounts under the
      accounts receivable line of credit provided by United Capital Funding
      Corp. (“United”)
      to Adamis Laboratories, Inc. (“Adamis Labs”) pursuant
      to the Factoring and Security Agreement dated as of January 22, 2009 (the
      “Agreement”),
      by and between United and Adamis Labs (“A/R Loan”) have been
      fully repaid and terminated and that the security interests on the assets
      of Adamis Labs in connection therewith have been terminated, including
      without limitation a copy of the executed satisfaction and release and
      filed UCC-3 termination statement.

            

    

    

    
      	
              (c)

            	
              A/R Loan
      Payoff.  To the extent not previously paid, the Company
      hereby authorizes and directs Gemini to pay on the Closing Date the amount
      of outstanding balance on the A/R Loan as instructed by the Company in
      order to payoff such A/R Loan on behalf of Adamis Labs, which amount paid
      will be deducted from the amount otherwise deliverable by Gemini for its
      Subscription Amount hereunder and shall constitute partial payment of its
      Subscription Amount in an
      amount equal to such payment.

            

    

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    5.    Expenses.  The
Company shall pay a non-refundable, non-accountable sum equal to $30,000 as and
for the Purchasers’ legal fees incurred in connection with the preparation of
the Transaction Documents and consummation of the Transactions, $20,000 of which
amount has already been paid and the balance of which will be offset by Gemini
from its Subscription Amount payment.  In addition, the Company shall
reimburse Gemini and the Purchasers an amount not to exceed a total of $2,500
for estimated UCC searches and filing fees and for estimated fees and expenses
incurred in connection the filing of documents with the United States Patent and
Trademark Office, which will be payable on the Closing Date out of funds
otherwise deliverable by Gemini for its Subscription Amount
hereunder.

    

    6.    Company
Address for Notices:

    

    
      	
              Adamis
      Pharmaceuticals Corporation

              2658
      Del Mar Heights Rd., #555

              Del
      Mar, CA 92014

              Facsimile:
      866.893.3622

              Email:
      adcarlo@aol.com

              Contact
      person: Dennis J. Carlo

               

            	
              with a copy to:

              Weintraub
      Genshlea Chediak

              400
      Capitol Mall, 11th floor

              Sacramento,
      CA 95814

              Facsimile:
      (916) 446-1611

              Email:
      kkelso@weintraub.com

              Contact
      person: Kevin Kelso, Esq.

            

    

    

    7.    Modifications
and Additional Terms.

    

    
      	
              (a)

            	
              Additional
      Documents.  In addition to the those items set forth in
      Section 2.3(a)(viii) of PST Document GTC, on the Closing Date the Company
      shall deliver or cause to be delivered to each Purchaser the
      following:

            

    

    

    
      	
               
      

            	
              (i)

            	
              a
      Security Agreement, in substantially the form of Exhibit B
      attached hereto, duly executed by the Company and its Subsidiaries (other
      than Biosyn, Inc. (“Biosyn));

            

    

    

    
      	
               
      

            	
              (ii)

            	
              a
      Guarantee, in substantially the form of Exhibit C
      attached hereto, duly executed by each of the Company’s Subsidiaries
      (other than Biosyn);

            

    

    

    
      	
               
      

            	
              (iii)

            	
              other
      Security Documents in form and substance reasonably satisfactory to the
      Requisite Purchasers, including without limitation any collateral
      assignment of the CA License Agreement requested by the Purchasers (which
      collateral assignment may be delivered by the Company at Closing with the
      consent of the licensor thereof provided within ten days following the
      Closing, which shall be a condition subsequent to the
      Closing);

            

    

    

    
      	
               
      

            	
              (iv)

            	
              irrevocable
      Lock Up Agreement(s), in substantially the form of Exhibit D
      attached hereto, duly executed and delivered by each of the Persons listed
      on Schedule 7(a)(iv) attached hereto;
and

            

    

    

    
      	
               
      

            	
              (v)

            	
              subordination
      agreements, in form and substance reasonably satisfactory to the Requisite
      Purchasers, executed by Dennis J. Carlo (“Carlo”) in favor of the
      Purchasers,  pursuant to which Carlo subordinates any and all
      Indebtedness of the Company owed to him to the Indebtedness of the Company
      owed to Purchasers under the
Notes.

            

    

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    

    
      	
              (b)

            	
              Modifications to PST Documents
      GTC and DEF.

            

    

    

    
      	
               
      

            	
              (i)

            	
              No Registration
      Rights.  Sections 6.1 through 6.3 of PST Document GTC are
      hereby deleted such that the Purchasers shall not have any registration
      rights except for the piggyback registration rights set forth in Section
      6.4 thereof.  Without the prior written consent of the Requisite
      Purchasers, the Company shall not file any registration statement under
      the Securities Act, or grant any registration rights to any Person, until
      after the date which is six (6) months following the Closing Date (other
      than a registration statement on Form S-4 in connection with the Merger as
      contemplated in the Merger Agreement or on Form S-8 in connection with
      securities issued to employees or directors pursuant to duly adopted
      equity incentive plans).  Notwithstanding the definition of
      “Registrable Securities” contained in PST Document DEF, Registrable
      Securities shall not include any Shares or Underlying Shares to the extent
      such securities may be sold pursuant to Rule 144 after one (1)
      year.  To the extent any Registrable Securities are registered
      under the Securities Act pursuant to Section 6.4 of PST Document GTC, the
      Purchasers shall have the same rights and obligations as the other selling
      stockholders in the Registration Statement except to the extent otherwise
      provided in PST Document GTC and except that the Purchasers shall not be
      entitled to the liquidated damages, if any, granted to such other selling
      stockholders unless otherwise agreed by the Company.  The Shares
      will be treated in a manner similar to other outstanding shares of the
      Company pursuant to the S-4 registration statement filed in connection
      with the Merger (and will be exchanged for La Jolla Common Stock in the
      same manner as such other shares) such that the shares of La Jolla Common
      Stock to be issued to stockholders of the Company in connection with the
      Merger and pursuant to the registration statement in exchange for shares
      of Common Stock, including the Shares, shall be registered and freely
      tradable upon completion of the
Merger.

            

    

    

    
      	
               
      

            	
              (ii)

            	
              GTC
      Sections.  The following provisions of PST Document GTC
      are hereby amended as follows:

            

    

    

    
      	
               
      

            	
              ·

            	
              In
      Section 3.1(b) (Execution and
      Validity), in the first sentence, between “further” and “action”
      insert “corporate, partnership or
similar”.

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 3.1(c) (No
      Conflicts), in clause (ii) replace “the Company or any Subsidiary”
      with “such Party or any of its
subsidiaries”.

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 3.2(g) (Short
      Sales and Confidentiality), in the phrase “provided that if the
      Transactions have been publicly disclosed” insert “material terms of the”
      before “Transactions”.

            

    

    
      	
               
      

            	
              ·

            	
              Sections
      3.3(d) and (e) are deleted in their
entirety.

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 3.4(g) (Public
      Filings), in the last full line add “, in light of the totality of
      the circumstances and public disclosures made,” before the words “not
      misleading”.

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 3.4(i) (Financial Statements),
      the first sentence shall be replaced with “Since the date of the most
      recent balance sheet contained in the Most Recent Fiscal Report, the
      Company and its Subsidiaries have not incurred any Liabilities other than
      those Liabilities incurred in the ordinary course of the Company's or its
      Subsidiaries' respective businesses which Liabilities, individually or in
      the aggregate, do not have, and could not reasonably be expected to result
      in, a Material Adverse Effect.”

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 3.4(j) (Material
      Changes), in the first sentence delete “audited” and replace “most
      Recent Annual Report” with “Most Recent Fiscal
  Report”.

            

    

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    
      	
               
      

            	
              ·

            	
              In
      Section 3.4(p) (Regulatory Permits),
      after the word “All” at the beginning of the second sentence add
      “material” before the word
“Permits”.

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 3.4(r) (Intellectual Property)
      (A) in the fourth sentence add “materially” before “interfered” and add
      “material” before “Intellectual Property”, (B) at the end of the fifth
      sentence add “except for instances that would not reasonably be expected
      to cause a Material Adverse Effect”, and (C) in the penultimate sentence
      add “imminent” before “new products” and after “developed” add “and ready
      to be commercialized”.

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 3.4(s) (Insurance), in clause
      (ii) add “material” before
“breach”.

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 3.4(t) (Tax
      Matters), in clause (ii) add “material” before “tax
      deficiency”.

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 3.4(x) (Sarbanes-Oxley), after
      “negative conclusions” add “required to be disclosed” in each
      instance.

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 3.4(y) (Internal
      Accounting Controls), in clause (iii) after “authorizations” add
      “and policies”.

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 3.4(z) (Corporate Records),
      replace the first sentence with “The minute books of the Company and each
      Subsidiary contain all existing records of all meetings and actions of the
      Board of Directors (and its committees) and the stockholders of the
      Company and such Subsidiary, respectively, and all such records are
      complete and accurate in all material
respects”.

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 3.4(ii) (Disclosure), replace
      “Form S-1 or From F-1” with “Form
S-3”.

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 4.7 (Reporting), at the end
      add “, to the extent not available on
EDGAR”.

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 4.8 (Securities
      Laws Disclosure), in clause (a) replace “Closing Date” with
      “execution and delivery of the Securities Purchase
    Agreement”.

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 4.13 (No
      Inconsistent Agreement), at the end add “in any material
      respect”.

            

    

    
      	
               
      

            	
              ·

            	
              For
      clarification, Section 4.15 (Stockholder Approval)
      is not applicable for this Transaction since the Common Stock is traded on
      the Bulletin Board which does not have a 20%
  Rule.

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 5.1 (Transfer
      Restrictions), the second sentence shall be replaced with “In
      connection with any transfer of Securities or Underlying Shares other than
      (a) pursuant to an effective Registration Statement or Rule 144(b)(1), (b)
      to the Company or to an affiliate of a Purchaser (that does not constitute
      a change in beneficial ownership), or (c) in connection with a pledge as
      contemplated in Section 5.3 below, the Company may require the transferor
      thereof to provide the Company with a legal opinion, in form and substance
      reasonably acceptable to the Company from counsel reasonably acceptable to
      the Company, or other evidence reasonably satisfactory to the Company, to
      the effect that such transfer does not require registration of such
      transferred securities under the Securities
  Act.”

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 5.2(a) (Legends), “Rule 144”
      shall be replaced with “Rule 144(b)(1)”, and in Section 5.2(b) (Removal of Legends),
      legend removal is subject to the Holder not being an Affiliate, and any
      opinion of counsel required before completion of the one year holding
      period under Rule 144 may require the Holder to represent to the Company
      in writing that it will sell such shares only in compliance with Rule 144
      or Section 4(1) of the Securities Act if such shares are not registered
      for resale under the Securities
Act.

            

    

    
      	
               
      

            	
              ·

            	
              For
      clarification, to the extent the terms of the Notes are inconsistent with
      Section 5.2(d) (Failure
      to Deliver Shares), the terms of the Notes shall
      control.

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 5.4 (Rule 144
      Information), in the first sentence after “As long as any Purchaser
      owns Securities and/or Underlying Shares”, add “(but not more than three
      years after the Closing Date)”.

            

    

    
      	
               
      

            	
              ·

            	
              For
      clarification, in Section 5.5 (Reservation of
      Securities), monthly Liquidated Damages shall cease to accrue upon
      the Company’s redemption of Underlying Shares pursuant to the last
      sentence thereof.

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 7.5 (Survival), at the end
      add “for four years following the Closing
Date”.

            

    

    
      	
               
      

            	
              ·

            	
              In
      Section 7.12 (Notices), replace “6:00
      p.m.” with “4:30 p.m.” in each
instance.

            

    

    

    
      	
               
      

            	
              (iii)

            	
              DEF
      Sections.  The following definitions contained in PST
      Document DEF are hereby amended as
follows:

            

    

    

    
      	
               
      

            	
              ·

            	
              “Bankruptcy Event” is
      hereby amended to delete clause (f)
therefrom.

            

    

    
      	
               
      

            	
              ·

            	
              “Covenant Expiration
      Date” is hereby amended to replace clause (b) thereof with “the
      first anniversary of the Closing
Date”.

            

    

    
      	
               
      

            	
              ·

            	
              “Legend Removal Date” is
      hereby amended to add at the end thereof “and such Purchaser is not an
      Affiliate of the Company.”

            

    

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

    
      	
               
      

            	
              ·

            	
              “Liens” is hereby
      amended to add at the end thereof “, and (f) liens created by the
      Transaction Documents”.

            

    

    
      	
               
      

            	
              ·

            	
              “Material Adverse
      Effect” is hereby amended to add “current” before “prospects” and
      to add at the end thereof “, other than to the extent such effects are due
      to (A) any change in the stock price or trading volume of the Company
      Common Stock (it being understood that the facts and circumstances giving
      rise to such change may be deemed to constitute, and may be taken into
      account in determining whether there has been, a Material Adverse Effect),
      or (B) any act or threat of terrorism or war anywhere in the world, any
      armed hostilities or terrorist activities anywhere in the world, any
      threat or escalation or armed hostilities or terrorist activities anywhere
      in the world or any governmental or other response or reaction to any of
      the foregoing.”

            

    

    
      	
               
      

            	
              ·

            	
              “Organization Documents”
      is hereby amended to replace “conduct” with “internal
      governance”.

            

    

    
      	
               
      

            	
              ·

            	
              “Recent
      Report” is hereby amended to add at the end thereof, “, and the Form S-4
      registration statement filed by La Jolla in connection with the proposed
      Merger, as in effect before the Closing Date, to the extent such
      registration statement includes information relating to the
      Company.

            

    

    

    
      	
              (c)

            	
              Additional Representations and
      Warranties.  The
      Company hereby represents and warrants to each Purchaser that, except as
      disclosed in a Recent Report, as of the date hereof and as of the Closing
      Date:

            

    

    

    
      	
               
      

            	
              (i)

            	
              FDA.  As
      to each product subject to the jurisdiction of the U.S. Food and Drug
      Administration (“FDA”) under the Federal
      Food, Drug and Cosmetic Act, as amended, and the regulations thereunder
      (“FDCA”) that is
      manufactured, packaged, labeled, tested, distributed, sold, and/or
      marketed by the Company or any of its Subsidiaries (each such product, a
      “Pharmaceutical
      Product”), such Pharmaceutical Product is being manufactured,
      packaged, labeled, tested, distributed, sold and/or marketed by the
      Company in compliance with all applicable requirements under FDCA and
      similar laws, rules and regulations relating to registration,
      investigational use, premarket clearance, licensure, or application
      approval, good manufacturing practices, good laboratory practices, good
      clinical practices, product listing, quotas, labeling, advertising, record
      keeping and filing of reports, except where the failure to be in
      compliance would not reasonably result in  a Material Adverse
      Effect.

            

    

    

    
      	
               
      

            	
              (ii)

            	
              Indebtedness.  Set
      forth on Schedule 3.4(f) of the Disclosure Schedule is a list of all
      Indebtedness of the Company, including the amounts outstanding with
      respect to each item of Indebtedness and each Person owed such
      Indebtedness.  Upon the request of any Purchaser, the Company
      shall furnish such Purchaser with any and all agreements and documents
      related to such Indebtedness.

            

    

    

    
      	
               
      

            	
              (iii)

            	
              Biosyn.  The
      value of each of Biosyn’s assets and Cellegy Holdings, Inc.’s (“Cellegy”) assets are not
      material and are insignificant relative to the value of the Company as a
      whole.  So long as any Notes are outstanding, the Company shall
      not transfer, or permit any Affiliate of the Company to transfer, any
      significant dollar amount of assets to Biosyn or Cellegy, and the Company
      shall ensure that neither Biosyn nor Cellegy engages in any operations
      other than operations that are immaterial relative to the value of the
      Company as a whole.  So long as any Notes are outstanding, in
      the event that at any time the value of Biosyn’s or Cellegy’s assets
      becomes material or not insignificant relative to the value of the Company
      as a whole, the Company shall promptly cause Biosyn and/or Cellegy, as the
      case may be, to execute and deliver to the Purchasers (A) a Security
      Agreement insubstantially the form of Exhibit B
      attached hereto and (B) a Guarantee in substantially the form of Exhibit C
      attached hereto.

            

    

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

    

    
      	
               
      

            	
              (iv)

            	
              Nevagen
      License.  That certain license agreement (“AC License Agreement”)
      dated as of July 28, 2006 between the Company’s wholly-owned Subsidiary,
      Adamis Corporation (f/k/a Adamis Pharmaceuticals Corporation), as licensee
      (“AC”), and
      Nevagen, LLC, a Nevada corporation (“Nevagen”), as licensor,
      pursuant to which AC licensed certain intellectual property from Nevagen
      as set forth therein, (A) is legal, valid, binding and enforceable and in
      full force and effect, and (B) has not been amended since its
      execution.  Neither AC nor, to the Company’s and AC’s knowledge
      Nevagen, is in breach or default under the AC License Agreement and, to
      the Company’s and AC’s knowledge, no event has occurred which with notice
      or lapse of time or both would constitute a breach or default or permit
      termination or modification of the AC License Agreement, and Adamis does
      not anticipate that it will breach or become in default under the AC
      License Agreement.  Notwithstanding anything contained in the
      Company’s Recent Reports, except as set forth on Schedule F to the
      Security Agreement, the Company and its Subsidiaries do not own or have an
      interest in (as licensee or otherwise) any patents, patent applications,
      trademarks or trademark applications that are material to the business of
      the Company and its Subsidiaries or have, or can be reasonably expected to
      have, any material value.  Nevagen currently owns all patents
      and patent applications set forth in Schedule F to the Security Agreement
      (including any patents issued for the patent applications set forth
      therein).

            

    

    

    
      	
              (d)

            	
              Additional
      Covenants.

            

    

    

    
      	
               
      

            	
              (i)

            	
              Lock-Up
      Agreements.  The Company shall enforce the provisions of
      the Lock-Up Agreements and shall place or cause to be placed “stop orders”
      on its books to prevent transfer of shares of Common Stock or other
      securities of the Company in violation of the Lock-Up
      Agreements.  The Company agrees not to take any action or allow
      any act to be taken which would be inconsistent with the Lock-Up
      Agreements nor amend or terminate any Lock-Up Agreement without the
      consent of the Requisite
Purchasers.

            

    

    

    
      	
               
      

            	
              (ii)

            	
              Subsequent Equity
      Sales.

            

    

    

    
      	
               
      

            	
              (A)

            	
              “Subsequent Financing”
      shall mean any issuance of shares of Common Stock, Convertible Securities
      or Options by the Company or any Subsidiary, other than an Exempt
      Issuance.

            

    

    

    
      	
               
      

            	
              (B)

            	
              From
      the date hereof until such time as no Purchaser holds any of the Notes,
      the Company shall be prohibited from effecting or entering into an
      agreement to effect any Subsequent Financing involving a Variable Rate
      Transaction, provided that this
      prohibition shall not apply to the extent that the effective conversion
      price, exercise price, exchange price or per share sale price (either
      initially or resulting from any adjustment other than proportional
      adjustments such as stock splits) is at least $0.20 and is not subject to
      reduction below $0.20 (such $0.20 figure to be appropriately and equitably
      adjusted for stock splits, combinations, stock dividends,
      recapitalizations and the like) and shall not apply to the extent the
      transaction is a Variable Rate Transaction solely because it contains
      standard price-based anti-dilution
protection.

            

    

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

    

    
      	
               
      

            	
              (C)

            	
              Without
      limiting the foregoing, from the date hereof until such time as no
      Purchaser holds any of the Notes, in the event the Company issues or sells
      any shares of Common Stock, Convertible Securities or Options or amends
      the transaction documents relating to any sale or issuance of Common
      Stock, Convertible Securities or Options, other than Exempt Issuances, if
      a Purchaser reasonably believes that the terms and conditions thereunder
      are more favorable to such investors than the terms and conditions granted
      under the Transaction Documents, upon notice to the Company by such
      Purchaser the Company shall amend the terms of this Transaction and the
      Transaction Documents so as to give the Purchasers the benefit of such
      more favorable terms or conditions.

            

    

    

    
      	
               
      

            	
              (D)

            	
              Without
      limiting the foregoing, if at any time prior to the Maturity Date (as
      defined in the Notes) the Company raises capital in a Subsequent
      Financing, other than from a sale solely of Common Stock at an effective
      per share sale price greater than the Conversion Price under the Notes
      (which Common Stock sale may include up to 50% warrant coverage, provided
      such warrants have (i) an exercise price greater than the Conversion
      Price, (ii) a term not more than five (5) years, (iii) no cashless
      exercise provision, and (iv) no price-based anti-dilution adjustment which
      can cause the exercise price to fall below such Conversion Price), then
      five (5) Trading Days following the closing of such Subsequent Financing
      at least 50% of the gross proceeds therefrom shall be paid to the
      Purchasers to redeem a portion of the Notes at a redemption price equal to
      110% of the principal amount being redeemed plus all accrued but unpaid
      interest thereon.  Any such redemption of Notes shall be
      effected on a pro rata basis based upon the then outstanding principal
      amount of Notes.  On or prior to any such closing the Company
      shall give written notice to each Purchaser specifying the intended
      closing date and the principal amount of such Purchaser’s Notes to be
      redeemed.  Notwithstanding anything contained herein, any
      Purchaser may reject any such redemption in whole or in
      part.  To the extent the Company is obligated to redeem any
      portion of the Notes pursuant to this Section but fails to do so, such
      default shall constitute an Event of Default under the
      Notes.  Notwithstanding anything contained in this paragraph,
      none of the La Jolla Net Cash (as defined in the Merger Agreement)
      obtained in the Merger shall be required to be paid to the Purchasers to
      redeem any portion of the Notes as a result of the
  Merger.

            

    

    

    
      	
               
      

            	
              (iii)

            	
              G-Max
      Note.  The Company represents, acknowledges and agrees
      that (A) each holder of Notes is a third party beneficiary of the
      subordination provisions under the G-Max Note (as defined in the Notes)
      and the Company agrees to enforce such subordination provisions for the
      benefit of the Note holders, and (B) the Indebtedness represented by the
      Notes constitutes “Senior Indebtedness” under and as defined in the G-Max
      Note.

            

    

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

    

    
      	
              (e)

            	
              Additional Closing
      Conditions.  The obligation of each Purchaser to purchase
      the Notes from the Company at the Closing shall be subject to the
      satisfaction, at or prior to the Closing, of each of the following
      conditions (in addition to those provided in PST Document GTC), provided
      that these conditions are for such Purchaser’s sole benefit and may be
      waived by such Purchaser (as to itself only) at any time in its sole
      discretion by providing the Company with prior written notice
      thereof:

            

    

    

    
      	
               
      

            	
              (i)

            	
              On
      or prior to the Closing Date the Company shall deliver or cause to be
      delivered to each Purchaser each of the documents set forth in Section
      7(a) above.

            

    

    

    
      	
              (f)

            	
              Other Terms and
      Provisions.

            

    

    

    
      	
               
      

            	
              (i)

            	
              La Jolla
      Merger.  The Purchasers hereby consent to the Merger in
      accordance with the terms of the Merger Agreement disclosed as an Exhibit
      to the Form 8-K filed on December 7, 2009, and no further consent of the
      Purchasers shall be required to effect the Merger so long as there are no
      material changes to the Merger
Agreement.

            

    

    

    
      	
               
      

            	
              (ii)

            	
              Attorneys.  For
      reasons of administrative convenience only, the Purchasers and their
      respective counsel have chosen to communicate with the Company through
      Peter J. Weisman, P.C.  Peter J. Weisman, P.C. does not
      represent any of the Purchasers except Gemini Master Fund, Ltd., and
      Weinstein Smith LLP does not represent any of the Purchasers except
      Kingsbrook Opportunities Master Fund
LP.

            

    

     

    [Signature Page
Follows]

    
      
         

      

      
        10

        
          

        

      

      
         

      

    

    IN
WITNESS WHEREOF, as of the date first written above, the Parties hereto have
duly executed, or caused their authorized officers to duly execute, this
Securities Purchase Agreement #ADMP-09-A with file name “SPA -- ADMP
v.6”.

    

    COMPANY:

    

    
      	
              ADAMIS
      PHARMACEUTICALS CORPORATION

            	 
      
	 
      	 
      	 
      
	
              By:

            	
              
                /s/
      Dennis J. Carlo

              

            	 
      
	
              Name:

            	
              Dennis
      J. Carlo

            	 
      
	
              Title:

            	
              CEO

            	 
      

    

    

    

    PURCHASER:

    

    1. Signature:

    

    
      	
              PARTNERSHIP,
      CORPORATION, LIMITED LIABILITY COMPANY OR TRUST:

            	 
      	
              INDIVIDUAL:

            
	 
      	 
      	 
      
	 
      	 
      	 
      
	
              (Print
      Name of Purchaser Entity)

            	 
      	
              (Print
      Name(s))

            

    

    

    

    
      	
              By:

            	 
      	 
      	 
      
	 
      	
              (Print
      name of authorized, executing entity, if any; if none, leave
      blank)

            	 
      	
              (Signature)

            

    

    

    

    
      	
              By:

            	 
      	 
      	 
      
	 
      	
              (Signature
      of Authorized Person)

            	 
      	
              (Joint-Owner
      Signature, if any)

            

    

    

    

    
      	 
      	 
      	 
      
	
              (Print
      Name and Title of Authorized Person)

            	 
      	 
      

    

    

    2.  Subscription
Amount:  $______________

    

    3.  Maximum Ownership
Percentage:

     

    The
Maximum Ownership Percentage shall be 9.9% if no box is checked
below.

    

    
      	
              □ 4.9%

            	
              □ 9.9%

            	
              □ Other:
      ______%

            	
              □
  None

            

    

    

    

    [Purchaser
Signature Page to Securities Purchase Agreement #ADMP-09-A P. 2/2]

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    Schedule
7(a)(iv)

    

    Dennis J.
Carlo

    David J.
Marguglio

    Richard
L. Aloi

    Robert O.
Hopkins  (provided that up to an aggregate of 250,000 shares held by
Mr. Hopkins may be sold within 30 days following the Closing Date so long as no
shares are sold at a price less than $0.22 per share)

     
 

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    Exhibit
A

    

    FORM OF 10% SENIOR SECURED
CONVERTIBLE NOTE

     

     

     

    A-1

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    Exhibit
B

    

    FORM OF SECURITY
AGREEMENT

     

     

     

    B-1

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    Exhibit
C

    

    FORM OF
GUARANTEE

     

     

     

    C-1

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    Exhibit
D

    

    FORM OF LOCK-UP
AGREEMENT

     

     

     

    D-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}]]